Nautilus Biotechnology, Inc. (NAUT)
2.83
-0.06
(-2.08%)
USD |
NASDAQ |
Feb 20, 16:00
2.83
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology Market Cap : 357.44M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nephros, Inc. | 43.57M |
| Prelude Therapeutics, Inc. | 172.88M |
| Pyxis Oncology, Inc. | 88.10M |
| ProKidney Corp. | 297.95M |
| Neumora Therapeutics, Inc. | 565.60M |
Market Cap Related Metrics
| Price to Book Value | 2.113 |
| Price | 2.83 |
| Earnings Yield | -17.60% |